Evidence map›Paper›PMID 27517918›Full record

ArticleInternational journal of molecular sciences2016

Anti-Atherogenic Properties of Allium ursinum Liophylisate: Impact on Lipoprotein Homeostasis and Cardiac Biomarkers in Hypercholesterolemic Rabbits.

Mariann Bombicz, Daniel Priksz, Balazs Varga, Rudolf Gesztelyi, Attila Kertesz, Peter Lengyel, Peter Balogh, Dezso Csupor, Judit Hohmann, Harjit Pal Bhattoa and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Evaluation of the Antioxidant Activity ofMolecules (Basel, Switzerland) · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Mariann BombiczDepartment of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen H-4032, Hungary. bombicz.mariann@pharm.unideb.hu.
Daniel PrikszDepartment of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen H-4032, Hungary. priksz.daniel@pharm.unideb.hu.
Balazs VargaDepartment of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen H-4032, Hungary. varga.balazs@pharm.unideb.hu.
Rudolf GesztelyiDepartment of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen H-4032, Hungary. gesztelyi.rudolf@pharm.unideb.hu.
Attila KerteszDepartment of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen H-4032, Hungary. dr.kertesz.attila@gmail.com.
Peter LengyelInstitute of Applied Informatics and Logistics, University of Debrecen, Debrecen H-4032, Hungary. lengyel.peter@econ.unideb.hu.
Peter BaloghDepartment of Research Methodology and Statistics, Institute of Sectoral Economics and Methodology, University of Debrecen, Debrecen H-4032, Hungary. balogh.peter@econ.unideb.hu.
Dezso CsuporDepartment of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Szeged H-6720, Hungary. csupor.dezso@pharmacognosy.hu.
Judit HohmannDepartment of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Szeged H-6720, Hungary. hohmann@pharm.u-szeged.hu.
Harjit Pal BhattoaDepartment of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen H-4032, Hungary. harjit@med.unideb.hu.
David D HainesDepartment of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen H-4032, Hungary. ddhaines2002@yahoo.com.
Bela JuhaszDepartment of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen H-4032, Hungary. juhasz.bela@pharm.unideb.hu.
University of Debrecen · HUUniversity of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present investigation evaluates the capacity of Allium ursinum (wild garlic) leaf lyophilisate (WGLL; alliin content: 0.261%) to mitigate cardiovascular damage in hypercholesterolemic rabbits. New Zealand rabbits were divided into three groups: (i) cholesterol-free rabbit chow (control); (ii) rabbit chow containing 2% cholesterol (hypercholesterolemic, HC); (iii) rabbit chow containing 2% cholesterol + 2% WGLL (hypercholesterolemic treated, HCT); for eight weeks. At the zero- and eight-week time points, echocardiographic measurements were made, along with the determination of basic serum parameters. Following the treatment period, after ischemia-reperfusion injury, hemodynamic parameters were measured using an isolated working heart model. Western blot analyses of heart tissue followed for evaluating protein expression and histochemical study for the atheroma status determination. WGLL treatment mediated increases in fractional shortening; right ventricular function; peak systolic velocity; tricuspidal annular systolic velocity in live animals; along with improved aortic and coronary flow. Western blot analysis revealed WGLL-associated increases in HO-1 protein and decreases in SOD-1 protein production. WGLL-associated decreases were observed in aortic atherosclerotic plaque coverage, plasma ApoB and the activity of LDH and CK (creatine kinase) in plasma. Plasma LDL was also significantly reduced. The results clearly demonstrate that WGLL has complex cardioprotective effects, suggesting future strategies for its use in prevention and therapy for atherosclerotic disorders.

Indexed as

AlliumAnimalsAtherosclerosisBiomarkersEchocardiographyHypercholesterolemiaLipoproteinsMalePlant ExtractsRabbitsBiomarkersLipoproteinsPlant ExtractsAllium speciesatherosclerosiscardiovascular homeostasisechocardiographylipoprotein

Identifiers

PMID27517918
PMCPMC5000681
OpenAlexW2485582514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.